# A Phase 1, Single and Multiple Dose Study of TAK-137

> **NCT02322606** · PHASE1 · WITHDRAWN · sponsor: **Takeda**

## Conditions studied

- Healthy Japanese Adult Male

## Interventions

- **DRUG:** TAK-137 5 mg tablet, TAK-137 placebo tablet
- **DRUG:** TAK-137 5 mg tablet, TAK-137 placebo tablet
- **DRUG:** TAK-137 5 mg tablet, TAK-137 placebo tablet or TAK-137 0.5 mg tablet, TAK-137 placebo tablet
- **DRUG:** TAK-137 5mg tablet, TAK-137 placebo tablet
- **DRUG:** TAK-137 5 mg tablet, TAK-137 placebo tablet
- **DRUG:** TAK-137 5mg tablet, TAK-137 placebo tablet

## Key facts

- **NCT ID:** NCT02322606
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2014-11
- **Primary completion:** 2015-05
- **Final completion:** 2015-05
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2015-11-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02322606

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02322606, "A Phase 1, Single and Multiple Dose Study of TAK-137". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02322606. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*